The Technical AnalystExchange: EURONEXT Sector: Healthcare Industry: Pharmaceutical Retailers
Raia Drogasil S.A. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.18% BRL27.60
America/New_York / 17 mai 2024 @ 16:07
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 47 337 mill |
| EPS: | 0.620 |
| P/E: | 44.52 |
| Earnings Date: | Aug 06, 2024 |
| SharesOutstanding: | 1 715.13 mill |
| Avg Daily Volume: | 7.57 mill |
| RATING 2024-05-17 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 2.61x |
| Company: PE 44.52 | sector: PE 17.08 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.00x |
| Company: PE 44.52 | industry: PE 44.38 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
BRL41.51 (50.40%) BRL13.91 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
BRL 27.01 - 28.19 ( +/- 2.14%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | BRL27.60 (-0.18% ) |
| Volume | 4.23 mill |
| Avg. Vol. | 7.57 mill |
| % of Avg. Vol | 55.85 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RADL3.SA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RADL3.SA
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.